Zofran Birth Defect MDL Finally Heading For Trial In Fall
By Brian Dowling · February 24, 2021, 3:42 PM EST
A Massachusetts federal judge running the first bellwether in multidistrict litigation over whether GlaxoSmithKline's anti-nausea medication Zofran causes birth defects said Wednesday that he's considering an October starting date after a...
To view the full article, register now.